Cargando…

cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas

Successful/effective cancer therapy in low grade lymphoma is often hampered by cell resistance to anti-neoplastic agents. The crucial mechanisms responsible for this phenomenon are poorly understood. Overcoming resistance of tumor cells to anticancer agents, such as proteasome inhibitors, could impr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manfè, Valentina, Biskup, Edyta, Willumsgaard, Ayalah, Skov, Anne Guldhammer, Palmieri, Dario, Gasparini, Pierluigi, Laganá, Alessandro, Woetmann, Anders, Ødum, Niels, Croce, Carlo Maria, Gniadecki, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602111/ https://www.ncbi.nlm.nih.gov/pubmed/23527180 http://dx.doi.org/10.1371/journal.pone.0059390

Ejemplares similares

miR-122 Regulates p53/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma
por: Manfè, Valentina, et al.
Publicado: (2012)

miR-125b induces cellular senescence in malignant melanoma
por: Nyholm, Anne Marie, et al.
Publicado: (2014)

Growth dynamics and cyclin expression in cutaneous T-cell lymphoma cell lines
por: Biskup, Edyta, et al.
Publicado: (2010)

A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010)

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012)

Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
por: Anderson, David A., et al.
Publicado: (2021)

Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification
por: Morrison, Gillian, et al.
Publicado: (2015)

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of cMYC oncoprotein
por: Geng, Chuandong, et al.
Publicado: (2017)

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
por: Sakr, Hany I., et al.
Publicado: (2017)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023)

Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma
por: Wei, Tianling, et al.
Publicado: (2016)

Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
por: Loftus, Róisín M., et al.
Publicado: (2018)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)

Association of CMYC polymorphisms with hepatoblastoma risk
por: Yang, Tianyou, et al.
Publicado: (2020)

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
por: Takizawa, Makiko, et al.
Publicado: (2008)

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis
por: Figueiredo, Jane C, et al.
Publicado: (2007)

cMyc increases cell number through uncoupling of cell division from cell size in CHO cells
por: Kuystermans, Darrin, et al.
Publicado: (2009)

The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc()()
por: Prensner, John R., et al.
Publicado: (2014)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
por: Luo, Haitao, et al.
Publicado: (2010)

MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
por: Chen, Pan, et al.
Publicado: (2016)

TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling
por: Song, Yuequn, et al.
Publicado: (2021)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Sequence-to-expression approach to identify etiological non-coding DNA variations in P53 and cMYC-driven diseases
por: Kin, Katherine, et al.
Publicado: (2023)

Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming
por: Simula, Luca, et al.
Publicado: (2018)

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model
por: Sokolowska, Olga, et al.
Publicado: (2022)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
por: George, Jasmine, et al.
Publicado: (2021)

Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
por: Jiang, Houxiang, et al.
Publicado: (2023)

Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
por: Abruzzese, Maria Pia, et al.
Publicado: (2016)

A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice
por: Hu, Y, et al.
Publicado: (2013)

microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer
por: Kim, Sinae, et al.
Publicado: (2018)

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
por: Boccadoro, Mario, et al.
Publicado: (2005)

Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway
por: Zhao, Xiaoxuan, et al.
Publicado: (2023)

Antitumor Effect of Pyrogallol via miR-134 Mediated S Phase Arrest and Inhibition of PI3K/AKT/Skp2/cMyc Signaling in Hepatocellular Carcinoma
por: Ahn, Hyojin, et al.
Publicado: (2019)

Concomitant Classic Hodgkin Lymphoma of Lymph Node and cMYC-Positive Burkitt Leukemia/Lymphoma of the Bone Marrow Presented Concurrently at the Time of Presentation: A Rare Combination of Discordant Lymphomas
por: Soliman, Dina S., et al.
Publicado: (2016)

Cytogenetic studies for cMYC, BCL2 and BCL6 genes in neoplasm: comparison of karyotype, FISH in paraffin-embedded tissue and FISH in methanol-acetic acid-fixed cells suspensions
por: Garcia, Caroline Henriques, et al.
Publicado: (2021)

Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma
por: Luo, Yanwei, et al.
Publicado: (2020)

Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial
por: Astakhova, Tatiana M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iqu98h8l77v30mgcj2m1hk2euj